Four-Week Interval Identified as Optimal for Circulating Tumor DNA Testing
Researchers determined that a four-week timeframe is optimal for circulating tumor DNA (ctDNA) testing. The study identified this specific time point as most effective for detecting ctDNA. The investigation centered around pinpointing the ideal window for ctDNA detection. Findings indicated that waiting four weeks before testing yielded the most reliable results. The research focused specifically on the temporal aspect of ctDNA testing, highlighting the importance of the interval between initial assessment and subsequent analysis.
Newsflash | Powered by GeneOnline AI
Date: April 28, 2025
LATEST
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Boehringer Ingelheim and Tempus AI Partner in Multi-Year Collaboration to Enhance Oncology Drug Development
2025-05-15
Study: Aligning U.S. Drug Prices with Europe Could Reduce American Life Expectancy by Six Months
2025-05-15